Start for free
Start for free
CF

Cancer Focus Fund

North America, Louisiana, United States, Shreveport

Description

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients.

Investor Profile

Cancer Focus Fund has made 7 investments, with 2 in the past 12 months and 71% as lead.

Stage Focus

  • Series Unknown (57%)
  • Series A (29%)
  • Seed (14%)

Country Focus

  • Israel (43%)
  • United States (43%)
  • Germany (14%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutics
  • Life Science
  • Pharmaceutical
  • Oncology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cancer Focus Fund frequently co-invest with?

Shavit Capital
Shavit Capital
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Peregrine Ventures
Peregrine Ventures
Asia, Tel Aviv, Israel, Or Yehuda
Co-Investments: 1
Dafna Capital Management
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Mirae Asset Venture Investment
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
aMoon Fund
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 1
Biotechnology Value Fund
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
OL
Co-Investments: 1
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Flerie Invest
Flerie Invest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Pavilion Capital
Pavilion Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Cancer Focus Fund?

March Biosciences

Houston, Texas, United States

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series AOct 23, 2024
Amount Raised: $28,400,000
Starget Pharma

Ramat Hasharon, Tel Aviv, Israel

Starget Pharma develops a novel somatostatin-based targeted therapy platform.

Biotechnology
Series UnknownOct 23, 2024
Amount Raised: $5,100,000
Eisbach Bio

Munich, Bayern, Germany

Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes.

Biotechnology
Series UnknownMar 21, 2024
Amount Raised: $4,500,000
March Biosciences

Houston, Texas, United States

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

Health CareMedicalTherapeutics
SeedNov 9, 2023
Amount Raised: $4,800,000
ImmunoGenesis

Houston, Texas, United States

ImmunoGenesis specializes in science-driven immune therapies for tumor treatment.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics
Series UnknownJun 27, 2023
Amount Raised: $4,500,000
Nectin Therapeutics

Jerusalem, Yerushalayim, Israel

Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.

BiotechnologyLife ScienceOncology
Series AMar 7, 2022
Amount Raised: $5,400,000
KAHR medical

Jerusalem, Yerushalayim, Israel

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 16, 2021
Amount Raised: $46,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator